Key to identifying, enriching mesenchymal stem cells found

A biomarker that enables researchers to accurately characterize the properties and function of mesenchymal stem cells (MSCs) in the body has been identified. MSCs are the focus of nearly 200 active clinical trials registered with the National Institutes of Health, targeting conditions such as bone fractures, cartilage injury, degenerative disc disease, and osteoarthritis.